Effects of gut microflora on hepatic damage after acute liver injury in rats

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 1, 2010, Pages 76-83

  Li, Yong Tao ^a   Wang, Li ^a   Chen, Yu ^a   Chen, Yun Bo ^a   Wang, Hua Ying ^a   Wu, Zhong Wen ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bacterial translocation; Cytokine; Endotoxin; Gut microflora; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; GALACTOSAMINE; GENTAMICIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; HISTOPATHOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; LIVER INJURY; MALE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RAT; SALMONELLA ENTERITIDIS; ANIMAL; BLOOD; ENZYMOLOGY; INTESTINE; KIDNEY; LIVER; LIVER DISEASE; LYMPH NODE; MESENTERY; METABOLISM; MICROBIOLOGY; PATHOLOGY; SPLEEN; SPRAGUE DAWLEY RAT; TOXIC HEPATITIS;

ANIMALS; BACTERIAL TRANSLOCATION; CYTOKINES; DRUG-INDUCED LIVER INJURY; ENDOTOXINS; ESCHERICHIA COLI; GALACTOSAMINE; GENTAMICINS; INTESTINAL MUCOSA; INTESTINES; KIDNEY; LIVER; LIVER DISEASES; LYMPH NODES; MALE; MESENTERY; PEYER'S PATCHES; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA ENTERITIDIS; SPLEEN;

EID: 75649096398     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31818ba467     Document Type: Article

References (27)

1. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519.
3. MacFie J, O'Boyle C, Mitchell C, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut. 1999;45:223-228.
4. Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126-133.
5. Jessica A. Clark, Craig M. Coopersmith. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock. 2007;28:384-393.
6. Stefan Zeuzem. Gut-liver axis. Int J Colorectal Dis. 2000;15:59-82.
7. Xing HC, Li LJ, Xu KJ, et al. Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemiareperfusion injury. J Gastroenterol Hepatol. 2006;21:647-656.
8. Fayol-Messaoudi D, Berger CN, Coconnier-Polter MH, Liévin-Le Moal V, Servin AL. pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol. 2005;71:6008-6013.
9. Rey J, Garin N, Spertini F, Corthésy B. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol. 2004;172:3026-3033.
10. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics-a novel approach in the management of food allergy. Allergy. 1999;54:909-915.
11. Li LJ, Wu ZW, Ma WH, Yu YS, Chen YG. Changes in intestinal microflora in patients with chronic severe hepatitis. Chin Med J. 2001; 114:869-872.
12. Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparationand mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997;11:853-858.
13. Sonnenborn U, Greinwald R. Escherichia coli im menschlichen darm: nuÈ tzlich, schaÈ dlich oder unbedeutend? Dtsch Med Wochenschr. 1990;115:906-912.
14. Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93:234-237.
15. Schutze GE, Schutze SE, Kirby RS. Extraintestinal salmonellosis in a children's hospital. Pediatr Infect Dis J. 1997;16:482-485.
16. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery. 1991;110: 303-310.
17. De Jonge E, Schultz MJ, Spanjaard LK, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized control trial. Lancet. 2003;362:1011-1016.
18. Marshall JC, Nathens AB. The gut in critical illness: evidence from human studies. Shock. 1996;(6 Suppl 1):S10-S16.
19. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1-10.
20. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC. Microbiology of bacterial translocation in humans. Gut. 1998;42: 29-35.
21. Nieuwenhuijzen GA, Goris RJ. The gut: the 'motor' of multiple organ dysfunction syndrome? Curr Opin Clin Nutr Metab Care. 1999;2:399-404.
22. Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H. Role of a serotonin precursor in development of gut microvilli. Am J Pathol. 2008;172:333-344.
23. Ewaschuk J, Endersby R, Thiel D, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007;46:841-850.
24. Guo W, Magnotti L, Ding J, Huang Q, Xu D, Deitch EA. Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. J Trauma. 2002;52:1178-1185.
25. Thurman RG. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol. 1998;275:G605-G611.
26. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 1995;108:218-224.
27. Nanji AA, Khettry U, Sadrzadeh SM. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med. 1994;205:243-247.